ENTITY

Apnimed (APMD US)

9
Analysis
Health Care • United States
Apnimed, Inc. is a pharmaceutical company. The Company focuses on the discovery, development, and commercialization of oral therapies that address the neurobiology of sleep-related breathing diseases. Apnimed operates in the United States.
more
Exchange Announcement • 09 Sep 2026 05:13

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 09 Sep 2026 05:10

Current Report (Form 8-K | Period ending 2026-09-08)

Exchange Announcement • 08 Sep 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 01 Aug 2026 04:38

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 01 Aug 2026 04:01

424B4 | Prospectus

x